Status:
COMPLETED
Evaluate the Depth and Duration of Anesthesia
Lead Sponsor:
ZARS Pharma Inc.
Collaborating Sponsors:
Endo Pharmaceuticals
Conditions:
Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of ...
Eligibility Criteria
Inclusion
- Had no known significant diseases
- Normal 12-lead electrocardiogram
- Willing to refrain from using any local topical preparations
Exclusion
- Taken over-the-counter (OTC) or prescription analgesics in any form within 24 hours
- Known allergy or sensitivity to any component of the Synera patch, including lidocaine, sympathomimetic amines, other local anesthetics of the amide type, epinephrine, or other patch components
- Had an active dermatological disease of any origin that may have interfered with their ability to participate
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00891163
Start Date
December 1 2006
End Date
April 1 2007
Last Update
May 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Medical Center, Thornton Hospital
San Diego, California, United States, 92037-7651